Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Other Non-Current Assets (2021 - 2025)

Historic Other Non-Current Assets for Coeptis Therapeutics Holdings (COEPW) over the last 5 years, with Q3 2025 value amounting to $8.2 million.

  • Coeptis Therapeutics Holdings' Other Non-Current Assets rose 791.65% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.2 million, marking a year-over-year increase of 791.65%. This contributed to the annual value of $7.8 million for FY2024, which is 17924.24% up from last year.
  • Coeptis Therapeutics Holdings' Other Non-Current Assets amounted to $8.2 million in Q3 2025, which was up 791.65% from $8.5 million recorded in Q2 2025.
  • In the past 5 years, Coeptis Therapeutics Holdings' Other Non-Current Assets ranged from a high of $8.8 million in Q1 2025 and a low of $2.5 million during Q1 2024
  • For the 5-year period, Coeptis Therapeutics Holdings' Other Non-Current Assets averaged around $5.4 million, with its median value being $4.3 million (2021).
  • Per our database at Business Quant, Coeptis Therapeutics Holdings' Other Non-Current Assets crashed by 3148.89% in 2024 and then surged by 25118.71% in 2025.
  • Over the past 5 years, Coeptis Therapeutics Holdings' Other Non-Current Assets (Quarter) stood at $4.6 million in 2021, then fell by 13.36% to $4.0 million in 2022, then dropped by 29.06% to $2.8 million in 2023, then soared by 179.24% to $7.8 million in 2024, then grew by 4.25% to $8.2 million in 2025.
  • Its Other Non-Current Assets was $8.2 million in Q3 2025, compared to $8.5 million in Q2 2025 and $8.8 million in Q1 2025.